Benzinga | Nov 12, 2020 06:30AM EST

HC Wainwright & Co. Maintains Buy on Cocrystal Pharma, Lowers Price Target to $4.5

HC Wainwright & Co. maintains Cocrystal Pharma (NASDAQ:COCP) with a Buy and lowers the price target from $5 to $4.5.